Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

NCT03674138 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT03674138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03674138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Not applicable
Overall status
Completed
Start date
September 12, 2018
Completion date
October 27, 2024
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer, depression, depressive disorder, generalized anxiety disorder, major depressive disorder